Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 15/20 | 0.47 |
| ▸ | SPHK2 | Q9NRA0 | 8/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.41 |
| ▸ | THRA | P10827 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19855331 | 0.99 | SPHK1 (0.48) | SPHK1SPHK2FFAR4THRATHRB | |
| SCHEMBL19855647 | 0.97 | SPHK1 (0.44) | SPHK1SPHK2FFAR4THRATHRB | |
| SCHEMBL19853889 | 0.96 | SPHK1 (0.43) | SPHK1SPHK2FFAR4THRATHRB | |
| SCHEMBL19855185 | 0.94 | SPHK1 (0.42) | SPHK1SPHK2FFAR4 | |
| SCHEMBL19855766 | 0.93 | SPHK1 (0.41) | SPHK1SPHK2FFAR4THRATHRB | |
| SCHEMBL19855763 | 0.93 | SPHK1 (0.41) | SPHK1SPHK2FFAR4THRATHRB | |
| SCHEMBL19855184 | 0.93 | SPHK1 (0.41) | SPHK1SPHK2FFAR4 | |
| SCHEMBL19855351 | 0.93 | SPHK1 (0.37) | SPHK1FFAR4 | |
| SCHEMBL21087930 | 0.92 | SPHK1 (0.40) | SPHK1SPHK2FFAR4 | |
| SCHEMBL21087927 | 0.92 | SPHK1 (0.40) | SPHK1SPHK2FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| EP-3466918-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2019-04-10 | — | — | EP | disclosed |
| WO-2018025974-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE | JNC株式会社 | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | SP1, PYM1, MPEG1 | SPHK1 448/4885SPHK2 916/4885FFAR4 1433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.